Objective: To evaluate the incidence and prevalence of autoimmune encephalitis and compare it to that of infectious encephalitis.
Background:Increasing evidence suggests that seizures and status epilepticus can be immune–mediated. We aimed to describe the clinical features of a...
Pfizer announced that the FDA accepted for Priority Review the company’s Biologics License Application (BLA) for TicoVac, its tick-borne encephalitis (TBE) vaccine for active immunization to prevent TBE in individuals 1 year of age and older.
Immune-mediated disorders of the CNS in children are a complex group of demyelinating, inflammatory, parainfectious and postinfectious disorders with heterogeneous pathobiological mechanisms and clinical manifestations...
IXIARO is indicated for active immunisation against Japanese encephalitis in adults, adolescents, children and infants aged 2 months and older.IXIARO should be considered for use in individuals at risk of exposure through travel or in the course of their occupation.
Chugai Pharmaceutical Co., Ltd. announced results from the Phase III LUMINESCE study of Enspryng (generic name: satralizumab (genetical recombination)), created by Chugai, as an investigational treatment for generalized myasthenia gravis (gMG).
The FDA has allowed marketing of the first cerebrospinal fluid (CSF) nucleic acid-based test for simultaneous detection of multiple pathogens...
Pfizer Inc. announced that the FDA has approved Ticovac (tick-borne encephalitis (TBE) vaccine) for active immunization to prevent TBE in individuals 1 year of age and older.
Aciclovir for infusion is indicated for the treatment of Herpes simplex infections in immunocompromised patients and severe initial genital herpes in the non-immunocompromised. Aciclovir for infusion is indicated for the prophylaxis of Herpes simplex infections in immunocompromised patients. Aciclovir for infusion is indicated for the treatment of Varicella zoster infections. Aciclovir for infusion is indicated for the treatment of herpes encephalitis. Aciclovir for infusion is indicated for the treatment of Herpes simplex infections in the neonate and infant up to three months of age.